About BrainCool

BrainCool's business concept is to develop and market products for the use of cooling in medicine. BrainCool's first project involves cooling stroke patients. Our product for brain cooling has been clinically tested in Sweden and the United Kingdom. A patent application has been submitted for the treatment method for strokes in the USA.
The company's second indication is to counteract oral mucositis, a serious side effect of cancer treatment.
The third indication is hypothermia treatment for cardiac arrest patients.